82 Labs, Inc. — Form D
82 Labs, Inc. of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-08. The offering totals $12.0M, of which $7.0M was reported sold. Industry: Other.
Offering
- Filed: 2021-11-08
- Form: D
- Accession: 0001737298-21-000006
- Industry: Other
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $7.0M
- Remaining: $5.0M
- Investors: 16
- Date of first sale: 2021-09-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-420312
Issuer
- Name: 82 Labs, Inc.
- CIK: 0001737298
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 3435 Wilshire Boulevard, 14th Floor, LOS ANGELES, CA, 90010
- Phone: (628) 245-2404
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Josh Groff | Director | Los Angeles, CA |
| Sisun Lee | Director | Los Angeles, CA |
| Hodong Nam | Director | Burlingame, CA |
| Josh Groff | Executive Officer | Los Angeles, CA |
| Sisun Lee | Executive Officer | Los Angeles, CA |
| Kenny Leung | Director | Los Angeles, CA |
Other filings by this issuer (1)
More